Pharmacologic and toxicologic evaluation of 2-(N-tetradecyl-N-ethylamino)-2-methyl-1,3-propanediol hydrochloride, an inhibitor of intestinal absorption.
D000818:Animals; D000891:Anti-Infective Agents, Local / Q000494:pharmacology*; D001067:Appetite Depressants / Q000494:pharmacology* / Q000633:toxicity; D001481:Basal Metabolism / Q000187:drug effects; D001693:Biological Transport, Active / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D003864:Depression, Chemical; D005123:Eye / Q000187:drug effects; D005769:Gastrointestinal Motility / Q000187:drug effects; D006128:Growth / Q000187:drug effects; D007082:Ileum / Q000502:physiology; D007408:Intestinal Absorption / Q000187:drug effects*; D007583:Jejunum / Q000502:physiology; D007700:Kinetics; D009092:Mucous Membrane / Q000187:drug effects; D009765:Obesity / Q000188:drug therapy; D010208:Papaverine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology; D010477:Perfusion; D011409:Propylene Glycols / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D013500:Surface Tension
D000891:Anti-Infective Agents, Local; D001067:Appetite Depressants; D010277:Parasympathomimetics; D011409:Propylene Glycols; D010208:Papaverine